Maglasang, Ronel T.

HRN: 23-95-35  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
10/25/2023
10/27/2023
PO
2.5ml
Q12H
Intestinal Parasitism
Checking Final Appropriateness 
10/25/2023
CEFUROXIME 750MG (VIAL)
10/25/2023
11/01/2023
IV
500mg
TID
Uti
Checking Final Appropriateness 
10/28/2023
CEFTRIAXONE 1G (VIAL)
10/28/2023
11/04/2023
IV
1.3mg
OD
ABI
Checking Final Appropriateness 
10/28/2023
MUPIROCIN 2%, 15G (TUBE)
10/28/2023
11/04/2023
TOPICAL
15g
BID
ABI
Checking Final Appropriateness 
10/28/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/28/2023
11/04/2023
PO
7ml
Tid
Amoebiasis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: